Brexit proposal details U.K.'s intent to stay in EMA

In a white paper released Friday, the U.K. reaffirmed its desire to remain in EMA and to establish a science and innovation accord with the EU.

The document detailed how the U.K. believes that drug manufacturers should need to undergo only one series of tests in either the U.K. or EU market, and thus is "seeking participation" in the EMA "as an active participant, albeit without voting rights, which would involve making an appropriate financial contribution." ...